Search results
2022 AAP Hyperbilirubinemia Guidelines What's new? Highlights the challenge of identifying G6PD deficiency in infants. Bases follow-up testing on the difference between bilirubin level and the phototherapy threshold. No more risk zones! Raises thresholds for phototherapy and exchange transfusion.
- Disclaimer
Disclaimer - BiliTool - Newborn values:
- BiliTool EMR
Five (5) are required (ageHours, totalBilirubin,...
- FAQ
Can I use BiliTool with transcutaneous bilirubin? TcB...
- Subscribe
Subscribe - BiliTool - Newborn values:
- About
About - BiliTool - Newborn values:
- Latest Features
October-November 2022 Updates. We are pleased to announce...
- Neurotoxicity Risk Factors
Neurotoxicity Risk Factors - BiliTool - Newborn values:
- BiliTool
The 2022 AAP Guideline (see KAS 7) has established a rapid...
- Disclaimer
Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation. Features. Neurotoxicity risk factors absent, present, or both. Plot multiple time points to assess trends.
19 maj 2010 · This guideline covers diagnosing and treating jaundice, which is caused by increased levels of bilirubin in the blood, in newborn babies (neonates). It aims to help detect or prevent very high levels of bilirubin, which can be harmful if not treated.
Neonatal jaundice. Treatment threshold graphs. NICE clinical guideline 98. Developed by the National Collaborating Centre for Women’s and Children’s Health. These treatment threshold graphs accompany the clinical guideline: ‘Neonatal jaundice’. They are also available as an implementation tool.
1 cze 2007 · To predict the occurrence of severe hyperbilirubinemia, it is therefore recommended that either TSB or TcB concentration be measured in all infants between 24 h and 72 h of life; if the infant does not require immediate treatment, the results should be plotted on the predictive nomogram to determine the risk of progression to severe ...
5 sie 2022 · This committee worked from 2014 to 2022 to review new evidence and to identify opportunities to clarify and improve the 2004 guideline. This report underwent extensive peer review by a wide array of clinicians and experts in neonatal hyperbilirubinemia and by parents of children with kernicterus.
Clinicians can evaluate a patient’s need for exchange transfusion using graphs in III.F of the Clinical Practice Guidelines, or using Bilitool.org. Decisions to initiate phototherapy or escalate care are guided by the gestational age, the hour-specific TSB, and the presence of risk factors for bilirubin neurotoxicity (below).
